FI113543B - Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi - Google Patents

Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi

Info

Publication number
FI113543B
FI113543B FI954579A FI954579A FI113543B FI 113543 B FI113543 B FI 113543B FI 954579 A FI954579 A FI 954579A FI 954579 A FI954579 A FI 954579A FI 113543 B FI113543 B FI 113543B
Authority
FI
Finland
Prior art keywords
cyclohexylmethylenedioxy
dihydroxypregna
16alpha
11beta
epimers
Prior art date
Application number
FI954579A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954579A0 (fi
FI954579A (fi
Inventor
Beate Gutterer
Hermann Amschler
Dieter Flockerzi
Richard Riedel
Stefan Postius
Michael Stoeck
Rolf Beume
Karl Zech
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of FI954579A0 publication Critical patent/FI954579A0/fi
Publication of FI954579A publication Critical patent/FI954579A/fi
Application granted granted Critical
Publication of FI113543B publication Critical patent/FI113543B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI954579A 1993-04-02 1995-09-27 Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi FI113543B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH102393 1993-04-02
PCT/EP1994/001015 WO1994022899A1 (de) 1993-04-02 1994-03-31 Neue prednisolonderivate

Publications (3)

Publication Number Publication Date
FI954579A0 FI954579A0 (fi) 1995-09-27
FI954579A FI954579A (fi) 1995-09-27
FI113543B true FI113543B (fi) 2004-05-14

Family

ID=4200650

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954579A FI113543B (fi) 1993-04-02 1995-09-27 Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi

Country Status (21)

Country Link
US (1) US5733901A (bg)
EP (1) EP0701565B1 (bg)
JP (1) JP3333210B2 (bg)
KR (1) KR100330941B1 (bg)
CN (1) CN1062869C (bg)
AT (1) ATE172739T1 (bg)
AU (1) AU683463B2 (bg)
BG (1) BG62491B1 (bg)
CZ (1) CZ287877B6 (bg)
DE (1) DE59407183D1 (bg)
DK (1) DK0701565T3 (bg)
ES (1) ES2124884T3 (bg)
FI (1) FI113543B (bg)
HU (1) HU220868B1 (bg)
NO (1) NO305990B1 (bg)
NZ (1) NZ265054A (bg)
PL (1) PL179489B1 (bg)
RU (1) RU2132854C1 (bg)
SK (1) SK281226B6 (bg)
UA (1) UA45311C2 (bg)
WO (1) WO1994022899A1 (bg)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
PL205674B1 (pl) * 2000-11-10 2010-05-31 Nycomed Gmbh Sposób wytwarzania 16,17-[(cykloheksylometyleno) bis (oksy)]-11,21-dihydroksypregna-1,4-dieno-3,20-dionu
KR101067795B1 (ko) 2002-08-30 2011-09-27 니코메드 게엠베하 알레르기성 비염을 치료하기 위한 사이클레소나이드 및 항히스타민제의 조합물의 용도
DK1572217T3 (da) 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
WO2004110460A1 (en) * 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
CA2538202C (en) * 2003-09-15 2013-01-15 Altana Pharma Ag Use of ciclesonide for the treatment of inflammatory bowel diseases
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
JP2008512428A (ja) * 2004-09-10 2008-04-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング シクレソニドとＳｙｋインヒビターとの組合せ物並びにその使用方法
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
US20100209508A1 (en) * 2005-06-14 2010-08-19 Corus Pharma, Inc. Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and Bronchoconstriction
WO2007054974A2 (en) * 2005-09-28 2007-05-18 Arch Pharmalab Limited A green chemistry process for the preparation of pregnadiene esters
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
JP2010503722A (ja) * 2006-09-19 2010-02-04 シプラ・リミテッド シクレソニドとその結晶変異体の調製方法
EP2262823B1 (en) * 2008-03-13 2013-01-23 Farmabios S.p.A. Process for the preparation of pregnane derivatives
ITMI20080645A1 (it) * 2008-04-11 2009-10-12 Ind Chimica Srl Procedimento per la preparazione di budesonide
CN102348714B (zh) * 2009-03-09 2015-01-07 三笠制药株式会社 甾族化合物
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
CN103421075B (zh) * 2012-05-16 2017-07-28 上海特化医药科技有限公司 孕烷衍生物16,17‑缩醛(酮)的制备方法
US20180126000A1 (en) 2016-06-02 2018-05-10 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
KR20200095477A (ko) 2017-12-01 2020-08-10 애브비 인코포레이티드 글루코코르티코이드 수용체 작용제 및 이의 면역접합체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.

Also Published As

Publication number Publication date
US5733901A (en) 1998-03-31
SK122395A3 (en) 1996-01-10
JPH08508278A (ja) 1996-09-03
CZ287877B6 (cs) 2001-03-14
KR100330941B1 (ko) 2002-10-12
CN1062869C (zh) 2001-03-07
NO305990B1 (no) 1999-08-30
FI954579A0 (fi) 1995-09-27
EP0701565B1 (de) 1998-10-28
ATE172739T1 (de) 1998-11-15
DK0701565T3 (da) 1999-07-12
PL179489B1 (pl) 2000-09-29
DE59407183D1 (de) 1998-12-03
RU2132854C1 (ru) 1999-07-10
WO1994022899A1 (de) 1994-10-13
NZ265054A (en) 1997-08-22
BG62491B1 (bg) 1999-12-30
UA45311C2 (uk) 2002-04-15
ES2124884T3 (es) 1999-02-16
NO953861L (no) 1995-09-29
CZ252995A3 (en) 1996-01-17
JP3333210B2 (ja) 2002-10-15
CN1120339A (zh) 1996-04-10
HUT72594A (en) 1996-05-28
HU220868B1 (en) 2002-06-29
EP0701565A1 (de) 1996-03-20
AU6538194A (en) 1994-10-24
PL311474A1 (en) 1996-02-19
HU9502819D0 (en) 1995-11-28
FI954579A (fi) 1995-09-27
AU683463B2 (en) 1997-11-13
NO953861D0 (no) 1995-09-29
BG100032A (bg) 1996-05-31
SK281226B6 (sk) 2001-01-18

Similar Documents

Publication Publication Date Title
FI113543B (fi) Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi
ES8705460A1 (es) Procedimiento para la obtencion de nuevos compuestos este- roides
NO2009024I1 (no) IUPAC (2'R)-2'- sykloheksyl-IIbeta-hydroksy-21-isobutyryloksy-16bH-dioksolo[5',4'.16,17]pregna-1,4-dien-3,20-dion
RU95119827A (ru) Новые производные преднизолона
NZ312303A (en) Novel nor-pregnanes for inducing hypothalamic effects
IL128535A (en) Process for r-epimer enrichment of 16, 17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11 beta, 16 alpha, 17 alpha-triol-3,20-dione derivatives
EP0711169A4 (en) ANDROSTANTEROIDS AS A NEUROCHEMICAL INITIATORS OF A CHANGE IN HUMAN HUMAN FUNCTION AND RELATED PHARMACEUTICAL PREPARATIONS AND METHODS
CA2258177A1 (en) 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
BR0115220A (pt) Processo para a produção de 16,17-(ciclohexilmetilen)bis(óxi) -11,21-diidróxi-pregna-1,4-dien-3,20-diona ou seu 21-isobutirato por transcetalização
KR970706297A (ko) 시상하부의 효능을 유도하기 위한 신규 에스트렌류(novel estrenes for inducing hypothalamic effects)
GB1508745A (en) Steroidal(16alpha,17-d)cyclohexenes
AU1847892A (en) New substituted 16-methyl steroid derivatives of pregna-1,4-diene-3,20-dione, their preparation, their use in the preparation of 16-methylene steroids and new intermediates
YU22903A (sh) 17alfa-fluoroalkil steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja
MX9700881A (es) Pregnanos y colanos como indicadores neuroquimicos del cambio en la funcion hipotalamica.
AU1200097A (en) 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them
JPS52136157A (en) Preparation of steroid 17-esters
JPS51149258A (en) A process for preparing steroid derivatives
GB1428347A (en) 6alpha-, 7alpha-dihydro-3h-cyclopropa-6,7-pregna-4,6-diene- 3,15,20-trione and related compound
CA2159627A1 (en) Novel prednisolone derivatives
FI946082A0 (fi) Menetelmä steroidisten perasyyliglykosidien valmistamiseksi
TW289730B (en) Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NYCOMED GMBH

Free format text: NYCOMED GMBH

PC Transfer of assignment of patent

Owner name: TAKEDA GMBH

MA Patent expired